Fanshuang Zhang
Overview
Explore the profile of Fanshuang Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
107
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu L, Rao W, Guo L, Zhang F, Li W, Ying J
J Cancer Res Clin Oncol
. 2025 Feb;
151(2):94.
PMID: 40016583
Purpose: The Kirsten rat sarcoma viral oncogene (KRAS) is the most frequently mutated oncogene in human cancers. Significant advancements have been made in targeted therapy and immunotherapy for this gene...
2.
Dai J, Jia J, Zhang F, Liu K, Xi Y, Yuan P, et al.
Cancer Res Commun
. 2024 May;
4(5):1351-1362.
PMID: 38695555
Significance: This study investigated the intricate epigenetic factor of mucosal melanomas contributed to the differential immune checkpoint inhibitor response, and found that PMME exhibited a global hypermethylation pattern and lower...
3.
Qiu T, Zhang F, Zheng B, Feng Z, Li W, Zeng H, et al.
Front Oncol
. 2023 Apr;
13:1064487.
PMID: 37064089
Background: Rapid profiling of the mutations is crucial to help clinicians choose the optimal treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer (NSCLC). Unfortunately, current diagnostic techniques, including ARMS-PCR...
4.
Yao Y, Song H, Zhang F, Liu J, Wang D, Feng Q, et al.
J Med Virol
. 2022 Aug;
95(1):e28104.
PMID: 36039015
Despite considerable variation in disease manifestations observed among coronavirus disease 2019 (COVID-19) patients infected with severe acute respiratory syndrome coronavirus 2, the risk factors predicting disease severity remain elusive. Recent...
5.
Yuan P, Guo C, Li L, Guo L, Zhang F, Ying J
JTO Clin Res Rep
. 2021 Sep;
2(2):100102.
PMID: 34589980
Introduction: Accurate results on the status of programmed cell death-ligand 1 (PD-L1) rely on not only the quality of immunohistochemistry testing but also the accuracy of the pathologic assessments. We...
6.
Li W, Qiu T, Dong L, Zhang F, Guo L, Ying J
J Cancer
. 2020 Apr;
11(13):3827-3833.
PMID: 32328187
: Chromosomal instability (CIN) and microsatellite instability (MSI) account for the major causes of colorectal cancer (CRC). As an important component of the CIN pathway, mutation is a negative prognostic...
7.
Li Y, Zhang F, Yuan P, Guo L, Jianming Y, He J
Thorac Cancer
. 2020 Apr;
11(6):1503-1511.
PMID: 32285618
Background: Clinical detection of EGFR-TKI resistance mechanism through tissue can be really challenging due to risks associated with the procedure. Thus, liquid biopsy, especially circulation tumor DNA (ctDNA) analysis, can...
8.
Qiu T, Li W, Zhang F, Wang B, Ying J
Cancer Biol Ther
. 2019 Oct;
21(2):170-177.
PMID: 31651223
: Many patients with advanced non-small cell lung cancer manifested with metastasis, and molecular heterogeneity may exhibit between primary and metastatic tumors. We sought to investigate the clinical detection strategy...
9.
Zhang F, Li X, Ni Y, Shan G, Gao Y
Sci China Life Sci
. 2019 May;
63(1):125-137.
PMID: 31102176
Biomarkers indicate changes associated with disease. Blood is relatively stable due to the homeostatic mechanisms of the body; however, urine accumulates metabolites from changes in the body, making it a...
10.
Song P, Zhang F, Li Y, Yang G, Li W, Ying J, et al.
Cancer Med
. 2019 Mar;
8(4):1551-1557.
PMID: 30843662
Background: TP53 mutations are the most prevalent mutations detected in non-small-cell lung cancer (NSCLC) and have been revealed as a negative prognostic biomarker of outcome. The impact of concomitant TP53...